Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya

Completed 200 enrolled Centers for Disease Control and Prevention Kenya Medical Research Institute · collab

NaSingle-groupOpen-label

Summary

One arm clinical trial of Nuvaring use for six months among 200 previously contracepting HIV-negative women (COCPs or DMPA) aged 18-35 in Kenya, where no vaginal rings are licensed/available for contraception or other indications. This was meant to be a formative research study to understand the predictors of acceptability and adherence to a contraceptive vaginal ring, and its immunoogical and microbiological effects over six months of product use.

Timeline

Start: 2014-04
Primary completion: 2015-08
Completion: 2015-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Etonogestrel	Unknown	—	Other
Subject	ethinyl estradiol	Small molecule	—	Other

Indications

No indication recorded.